Full-Time
Posted on 4/18/2025
Develops and manufactures biopharmaceutical products
No salary listed
Mid
Sydney NSW, Australia
Hybrid work location; specific in-office days not mentioned.
Get referrals →
You have ways to get a Pfizer referral from your network.
Applications through a referral are 3x more likely to get an interview!
Upload your resume to see how it matches 15 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Pfizer develops and manufactures healthcare products, focusing on medicines and vaccines. The company conducts extensive research to create new treatments, which are then sold to governments, healthcare providers, and patients around the world. Pfizer's products include vaccines, cancer treatments, and other specialized medications. A key aspect of Pfizer's work is its partnership with BioNTech to produce a vaccine for COVID-19, showcasing its role in addressing public health challenges. Unlike many competitors, Pfizer emphasizes not only the development of new drugs but also initiatives to ensure that vaccines reach underserved communities. The company's goal is to continuously expand its range of treatments and improve global health outcomes.
Company Size
10,001+
Company Stage
IPO
Headquarters
New York City, New York
Founded
1849
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Vacation
Paid Sick Leave
Paid Holidays
Hybrid Work Options
Relocation Assistance
Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding
Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The
The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.
The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.
New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio's EDAPT® platform is